ClinicalTrials.gov
ClinicalTrials.gov Menu

Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02371980
Recruitment Status : Active, not recruiting
First Posted : February 26, 2015
Last Update Posted : June 21, 2018
Sponsor:
Information provided by (Responsible Party):
Takeda

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : May 1, 2019
  Estimated Study Completion Date : May 1, 2019